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echocardiography accurately correlates with subsequent recovery
of LV function and confers a benign prognosis.
Takotsubo cardiomyopathye Review of our 36
cases
S. Phaujdar, V. Sharma, A.P. Arora, L.C. Gupta, T. Roy
National Heart Institute, New Delhi, India
Objectives: We aimed to describe clinical features of emergency
department patients finally diagnosed to have TC and to delineate
its causal role.
Methods: We reviewed the charts retrospectively to analyze all
patients who presented in our Institution with acute coronary
syndrome (ACS) between June 2010 & May 2014, and later diag-
nosed with TC as per the Mayo clinic diagnostic criteria. Absence
of significant coronary stenosis was confirmed by coronary angi-
ography or coronary computed-tomography angiography. Clinical
characteristics & laboratory data were obtained from reviewing
medical records. We finally analyzed factors from several studies
(including ours) to evaluate the true causality of stress in the
development of TC.
Results: 36 out of 537 patients were found to have TC after review
of charts. The median age was 42 years (range 23 to 67 years) and
26 of themwere females; 34% pre-menopausal, youngest with age
31 years. 68% and 56% of them had known hypertension and
diabetesmellitus respectively. Presenting symptomswere divided
in 3 groups. Group I (n¼12, 33%) had mental stress in form of
anxiety; Group II (n¼18, 50%) had chest pain mimicking ACS
without anxiety; and Group III (n¼6, 17%) had other medical
problems (seizures, post-operative, post chemotherapy, acute
asthma / COPD). Mean ejection fraction at the presentation is
28.6% and at TC resolution is 58.3%. Median troponin I level was
1.69 ng/ml (0.46-2.29), excluding the patients who underwent
cardiopulmonary resuscitation. Coronary angiographies of 30
patients were normal and remaining 6 patients had non-critical
stenosis. Cardiogenic shock was the presenting symptoms in 4 of
them; none of the present patient registry has died.
Conclusion: Most of the patients with TC were found to be post-
menopausal females. Stressful events are often not identified in
emergency department. The causative nature of stress in the
development of TC cannot be firmly established from any existing
data.
Behavioral changes in LV torsion in patients with
HCM as compared to normal subjects
S. Agarwal, R.K. Shetty, K. Nayak, J. Samanth, R.P. Reddy, U. Pai,
V.G. Raman
KMC, Manipal, India
Objectives: The main objectives of our study are 1) To assess
myocardial dysfunction in patients with HCM using tissue
Doppler indices 2) To assess myocardial dysfunction by strain
imaging using tissue Doppler imaging and 2-D speckle tracking
echocardiography.
Background: Hypertrophic cardiomyopathy, an autosomal domi-
nant disorder due to mutation of genes encoding sarcomeric
proteins, leads to left ventricular diastolic dysfunction. Recently
the research in this area suggests systolic dysfunction exists in
patients with hypertrophic cardiomyopathy even though tradi-
tional measures of systolic dysfunction are normal.
Methods: Total 18 patients diagnosed with hypertrophic cardio-
myopathy according to echocardiography parameters i.e. thick-
ness of interventricular septum/posterior wall thickness was >1.3
or hypertrophy involving apex only with or without left ventric-
ular outflow tract obstruction were included in the study andwere
compared with normal age-matched control. We measured tor-
sion and strain imaging aswell as strain imaging by tissue Doppler
echocardiography.
Results: The result of the study showed that there is considerable
increased torsion was observed in patients with hypertrophic
cardiomyopathy as compared to normal subjects (16.61+7.43
vs10.42+4.73, p¼0.0005). Tissue Doppler indices - systolic annular
velocity (7.7+0.7 vs. 8.7+1.00, p¼0.012) and lateral wall E/E’
(12.52+5.27 vs. 6.66+1.67, p<0.001) were significantly different in
patients with hypertrophic cardiomyopathy and normal subjects.
The average systolic strain and strain rate as well as diastolic
strain rate were significantly different in both the groups when
strain imaging performed by tissue Doppler echocardiography.
Conclusions: The global subtle systolic dysfunction, as measured
by LV torsion and strain imaging, is present in patients with HCM
even though the patients are having normal ejection fraction or
fraction shortening.
Can we predict the degree of hypertrophy and
segmental distribution in cases of Hypertrophic
Cardio Myopathy (HCM)
K.P. Sajith, Janardhana Rao Babburi, M. Sitaram, J. Shiv Kumar
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Objectives: The aim of the study was to compare and correlate the
degree and distribution of LV hypertrophy detected by various
Echocardiographic methods with that of electrocardiographic
findings, in cases of HCM.
Methods: the study population included 80 patients who were
diagnosed as HCM by available echocardiographic methods. Four
basic patterns of distribution of hypertrophy were identified by
echocardiography. TYPE I was confined to anterior segment of the
interventricular septum. TYPE II involved both anterior and pos-
terior segments. TYPE III involved both the mid portions of the
septum. TYPE IV involved the apex and posterior part of the
septum. Great care was taken to make an accurate short axis left
ventricular sweep from aortic root to apex ensuring approximate
circular cavity through out. M-Mode recordings were studied for
the presence ofmid systolic closure of the aortic valve and systolic
anterior motion of the mitral valve. The various ECG changes that
were noted in cases of HCM like LVH, deep T inversions, Q waves,
and left and right atrial abnormalities were compared and
analyzed with that of the four basic patterns of distribution of
hypertrophy.
Results: 25 patients had a TYPE I pattern and in them LVH was
seen predominantly in 89.5 % followed by deep S wave in 21.1 %,
left atrial abnormality in 15.8 % and normal ECG was found in 10.5
% and right atrial abnormality was noted in 5.3 %. TYPE II was
found in 24 patients and in them LVH was seen predominantly in
88.9 % followed by pseudo infarct pattern in 33.3 %, deep S waves
in 27.8 % and left atrial abnormality in 16.7 %. 14 patients had TYPE
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III pattern and in them interestingly normal ECG was seen in 50 %
and in another 50 % LVHwith no strain was noted. QS pattern was
seen in 30.4 % and left atrial abnormality in 21.6 %. TYPE IV pattern
was seen in 17 patients and in which 16 patients (94.1% ) had a
characteristic V4 R wave > 20 mm with deep T inversions in pre-
cordial leads. This unique pattern of electrocardiographic findings
had a sensitivity of 93 % for TYPE IV HCM.
Conclusions: Both symmetrical and asymmetrical hypertrophy
was noted in cases of HCM with or without obstruction. In cases
with asymmetrical hypertrophy (ASH), the hypertrophy was pre-
dominantly distributed either in the upper or lower septum,
lateral wall and posterior wall. The anterior ventricular septum
was predominantly was the most frequently hypertrophied
segment of the left ventricle seen in 78.3 %, followed by posterior
part of the septum in 58.33 %, and lateral free wall in 35 %. Pos-
terior free wall was preferentially spared and was thickened in
only 5 % of the patients. Except for the classical pattern of V4 R
wave of more than 20 mm with deep T inversions in precordial
leads in 94.1 % of TYPE IV hypertrophy, no other singular echo-
cardiographic pattern seemed to be very classical for the specific
distribution of hypertrophy.
Escherichia coli sepsis as a precipitant of stress
cardiomyopathy: A systematic review
M. Subramanian, P. Arthur, S. Gopalan, S. Ramadurai
Sri Ramachandra University, Chennai, India
Background: Stress cardiomyopathy (SC) is a novel cardiac syn-
drome characterized by peculiar, transient left ventricular
dysfunction in the absence of significant coronary occlusion.Ex-
acerbations of chronic medical conditions and sepsis are common
precipitants that precede the “myocardial stunning.”There is ev-
idence that inflammatory cytokines released by Escherisca coli
and lipopolysaccharide administration cause decreased cardiac
myofilament responsiveness and contractility.
Methods: The present systematic review aimed to report an
updated case series of SC precipitated by E.coli sepsis in an
attempt to summarize their demographic and clinical character-
istics. A systematic search through Medline archives accessed by
Pudmed (1950-2013) for all such case reports matching our inclu-
sion criterion was performed. Overall, four such cases were
eligible and we included our patient with SC with E.coli sepsis as
the fifth report. Demographic, clinical, electrocardiographic, and
echocardiographic characteristics were compared and evaluated.
Results: There was a greater male predominance with an average
age of 56 years. The most common ECG abnormalities were ST
segment elevation in lateral leads (40%) and anterior leads (60%).
There were no fatal outcomes in the cases reported in this anal-
ysis. The average time to achieve recovery of clinical, biochemical,
and echocardiographic abnormalities was 17 days.
Conclusion: In comparison to most cases of SC reported in liter-
ature due to other stressors, E.coli sepsis SC are younger and show
a greater male predominance. Other unique characteristics of this
subset of patients are ST segment elevation in lateral leads,
modest increase in troponin levels, and relatively faster complete
recovery. Patients in whom E.coli sepsis is the precipitating factor
of SC have a different spectrum of clinical, biochemical, and
electrocardiographic changes. A high index of clinical suspicion is
essential in the diagnosis and treatment of these patients.
Effect of Ivabradine in patients with heart failure
in whom beta blockers were contraindicated
Aditya Chaudhary, Anurag Rawat
Himalayan institute of medical sciences, India
Background: Heart failure is associated with high mortality and
morbidity. Tachycardia is an important risk factor for adverse out-
comes. Betablockers are important part of heart failure manage-
ment as they reducesmortality significantly.Weassessed the effect
of heart-rate reduction by the ivabradine on outcomes in heart
failure in patients in whom beta blockers were contraindicated.
Methods: Patients were eligible for participation in this study if
they had symptomatic heart failure with left-ventricular ejection
fraction of 35% or lower, were in sinus rhythm with heart rate
more than 75 bpm who were admitted with aggravation of
symptoms, and beta blockers were contraindicated. Patients were
given ivabradine titrated to a maximum of 7$5 mg twice daily or
matching placebo The primary endpoint was the composite of
cardiovascular death or hospital admission for worsening heart
failure.
Result: We evaluated 1500 patients of heart failure from Januaury
2010 till June 2014.Out of 1500 patients, 800 patients were ineli-
gible for betablockers in view of low blood pressure. Out of rest 700
patients, 350 patients received ivabradine and 350 patients were
given placebo. 60% patients were males and rest were females.
They were followed for more than two years. There was no sig-
nificant difference in mortality between the two groups as 24
patients from ivabradine and 27 patients from placebo group
expired ( p - non significant). There was not much difference in
hospital admissions due to worsening of heart failure. (82 patients
from ivabradine group and 87 patients from placebo group got
admitted.), No significant side effects were noted with ivabradine.
Conclusion: There was no significant difference in mortality and
morbidity with ivabradine therapy in patients with heart failure in
whom betablockers were contraindicated. Hospitilization was
more or less same in both the groups.
Effects of ivabradine on left ventricular function in
patients with ischemic heart failure
Mayuresh P. Chaudhari, Praloy Chakraborty, Swapnil P. Pathak,
H.S. Isser, Sandeep Bansal
Safdarjang Hospital and Vardhman Mahavir Medical College, New
Delhi, India
Background: Ivabradine, selective If channel blocker, has been
shown to reduce recurrent hospitalization due to worsening of
heart failure. Role of this agent on left ventricular function in
patients with ischemic heart failure is still unexplored.
Aims and objectives: This study was planned to assess the effects
of addition of ivabradine to optimal medical therapy(OMT) in
patients of ischemic heart failure with systolic dysfunction on Left
ventricular function, Exercise duration, Serum Brain Natriuretic
Peptide (BNP) levels and Health-related quality of life.
Methods: In this open-label, randomized, a total number of 158
patients of stable, ischemic heart failure were included and were
randomly assigned into OMT group (n¼80) and ivabradine group
(n¼78). Baseline assessments included assessment of Left ven-
tricular dimension and Left ventricular ejection fraction (LVEF),
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